These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38182107)

  • 1. Retrospective Case Control Matched Comparison of the Antegrade Versus Retrograde Strategy After Antegrade Recanalisation Failure in Complex de novo Femoropopliteal Occlusive Lesions.
    Trenkler C; Blessing E; Jehn A; Karcher J; Schoefthaler C; Schmidt A; Korosoglou G
    Eur J Vasc Endovasc Surg; 2024 May; 67(5):799-808. PubMed ID: 38182107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ante-versus retrograde access for the endovascular treatment of long and calcified, de novo femoropopliteal occlusive lesions.
    Giusca S; Lichtenberg M; Hagstotz S; Eisenbach C; Katus HA; Erbel C; Korosoglou G
    Heart Vessels; 2020 Mar; 35(3):346-359. PubMed ID: 31531718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BioMimics 3D Helical Centreline Nitinol Stent in Chronic Limb Threatening Ischaemia and Complex Lesions: Three Year Outcomes of the MIMICS-3D Registry.
    Rammos C; Zeller T; Piorkowski M; Deloose K; Hertting K; Sesselmann V; Tepe G; Gaines P; Lichtenberg M;
    Eur J Vasc Endovasc Surg; 2024 Jun; 67(6):923-932. PubMed ID: 38447693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anterolateral retrograde access to the distal popliteal artery and to the tibioperoneal trunk for recanalization of femoropopliteal chronic total occlusions.
    Silvestro M; Palena LM; Manzi M; Gómez-Jabalera E; Vishwanath D; Casini A; Ferraresi R
    J Vasc Surg; 2018 Dec; 68(6):1824-1832. PubMed ID: 30126786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.
    Torsello G; Stavroulakis K; Brodmann M; Micari A; Tepe G; Veroux P; Benko A; Choi D; Vermassen FEG; Jaff MR; Guo J; Dobranszki R; Zeller T;
    J Endovasc Ther; 2020 Oct; 27(5):693-705. PubMed ID: 32583749
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of femoropopliteal endovascular interventions on subsequent open bypass.
    Gifford SM; Fleming MD; Mendes BC; Stauffer KC; De Martino RR; Oderich GS; Gloviczki P; Bower TC
    J Vasc Surg; 2016 Sep; 64(3):623-8. PubMed ID: 27288105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes.
    Rodoplu O; Oztas DM; Meric M; Beyaz MO; Ulukan MO; Yildiz CE; Unal O; Ugurlucan M
    Ann Vasc Surg; 2021 May; 73():222-233. PubMed ID: 33359329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Endovascular Versus Bypass Surgery in Femoropopliteal TASC II D Lesions: A Single-Center Study.
    Veraldi GF; Mezzetto L; Macrì M; Criscenti P; Corvasce A; Poli R
    Ann Vasc Surg; 2018 Feb; 47():179-187. PubMed ID: 28943491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, clinical outcome, and fracture rate of femoropopliteal stenting using a 4F compatible delivery system.
    Sarkadi H; Bérczi V; Kollár A; Kiss D; Jakabfi P; Végh EM; Nemes B; Merkely B; Hüttl K; Dósa E
    Eur J Vasc Endovasc Surg; 2015 Feb; 49(2):199-204. PubMed ID: 25579877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with failed femoropopliteal covered stents are more likely to present with acute limb ischemia than those with failed femoropopliteal bare metal stents.
    DeCarlo C; Boitano LT; Latz CA; Png CYM; Lee S; Dua A; Patel V; Schwartz SI
    J Vasc Surg; 2021 Jul; 74(1):161-169.e1. PubMed ID: 33548436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vessel Calcification as a Risk Factor for In-Stent Restenosis in Complex Femoropopliteal Lesions After Zilver PTX Paclitaxel-Coated Stent Placement.
    Ichihashi S; Shibata T; Fujimura N; Nagatomi S; Yamamoto H; Kyuragi R; Adachi A; Iwakoshi S; Bolstad F; Saeki K; Obayashi K; Kichikawa K
    J Endovasc Ther; 2019 Oct; 26(5):613-620. PubMed ID: 31257994
    [No Abstract]   [Full Text] [Related]  

  • 12. Outcomes of Endovascular Therapy With the Controlled Antegrade Retrograde Subintimal Tracking (CART) or Reverse CART Technique for Long Infrainguinal Occlusions.
    Chou HH; Huang HL; Hsieh CA; Jang SJ; Cheng ST; Tsai SC; Wu TY; Ko YL
    J Endovasc Ther; 2016 Apr; 23(2):330-8. PubMed ID: 26862146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Coated Balloon Treatment for Femoropopliteal Artery Disease: The IN.PACT Global Study De Novo In-Stent Restenosis Imaging Cohort.
    Brodmann M; Keirse K; Scheinert D; Spak L; Jaff MR; Schmahl R; Li P; Zeller T;
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2113-2123. PubMed ID: 29050631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study.
    Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S
    J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of drug-coated balloon angioplasty versus uncoated balloon angioplasty in treatment of total occlusions with severe femoropopliteal lesions: An additional analysis from the AcoArt I study.
    Sun G; Liu J; Jia S; Zhang J; Zhuang B; Jia X; Fu W; Wu D; Wang F; Zhao Y; Guo P; Bi W; Wang S; Guo W;
    Vascular; 2021 Jun; 29(3):340-349. PubMed ID: 32903168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viabahn Stent Graft for the Endovascular Treatment of Occlusive Lesions in the Femoropopliteal Artery: A Retrospective Cohort Study with 4-Year Follow-Up.
    Ni Q; Yang S; Xue G; Zhou Z; Zhang L; Ye M
    Ann Vasc Surg; 2020 Jul; 66():573-579. PubMed ID: 31743785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-level meta-analysis of 999 claudicants undergoing primary femoropopliteal nitinol stent implantation.
    Rocha-Singh KJ; Beckman JA; Ansel G; Lyden SP; Schneider P; Mehta M; Dake M; Mullin CM; Jaff MR;
    Catheter Cardiovasc Interv; 2017 Jun; 89(7):1250-1256. PubMed ID: 28303688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Real-World Experience With the Supera Interwoven Nitinol Stent in Femoropopliteal Arteries: Midterm Patency Results and Failure Analysis.
    Myint M; Schouten O; Bourke V; Thomas SD; Lennox AF; Varcoe RL
    J Endovasc Ther; 2016 Jun; 23(3):433-41. PubMed ID: 27004494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of native superficial femoral artery chronic total occlusion recanalization after failed femoropopliteal bypass.
    Davies MG; El-Sayed HF
    J Vasc Surg; 2017 Mar; 65(3):726-733. PubMed ID: 28236917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.
    Mwipatayi BP; Perera K; Daneshmand A; Daniel R; Wong J; Thomas SD; Burrows SA
    Vascular; 2018 Feb; 26(1):3-11. PubMed ID: 28436316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.